Respiratory syncytial virus (RSV)
Peer reviewed by Dr Krishna Vakharia, MRCGPAuthored by Dr Doug McKechnie, MRCGPOriginally published 5 Nov 2024
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
In this series:Respiratory syncytial virus (RSV) vaccination
Respiratory syncytial virus (RSV) is a common infection which usually causes mild cold-like symptoms but can be more serious especially for babies, toddlers, and older people. Here we explain what causes it, what its symptoms are, and how it is treated.
At a glance
Respiratory syncytial virus (RSV) is a common virus often causing mild illnesses like the common cold.
It can lead to more serious infections, like bronchiolitis, in babies and older adults.
Symptoms vary but can include runny nose, cough, fever, and difficulty breathing.
RSV spreads through droplets from coughs and sneezes, and by touching contaminated surfaces.
Treatment for RSV usually involves managing symptoms as the body clears the virus.
Hospital treatment may be needed for severe infections, especially in babies and older adults.
Call 999 if a baby with RSV shows severe breathing difficulties, grunting, or blue lips.
Video picks for Viral infectionsVideo library
What is respiratory syncytial virus (RSV)?
Respiratory syncytial virus (RSV) is a common virus that usually causes mild illnesses such as the common cold in older children and adults. It can cause more serious infections in babies, toddlers, and older adults.
What is RSV in babies?
In babies, RSV is the most common cause of bronchiolitis, which is inflammation of the small airways of the lungs. Bronchiolitis is very common and usually happens in the winter months during the RSV season. Most children have a mild illness, but some need hospital treatment. Very rarely, bronchiolitis can be deadly.
See bronchiolitis for more detail.
RSV symptoms
RSV can cause infections in your:
Upper respiratory tract - nose, throat, sinuses, voice box (larynx), and windpipe( trachea).
Lower respiratory tract - the lungs and lower airways (bronchi).
The symptoms are different depending on which parts are affected and between adults and younger children.
RSV symptoms in adults
In adults, RSV commonly causes an upper respiratory tract infection. This can cause:
A blocked or runny nose.
Sneezing.
Cough.
Sore throat.
Headache.
High temperature (fever).
A hoarse voice (laryngitis).
These symptoms can be caused by lots of different respiratory viruses, and often there is no way to tell which one is causing it without testing.
However, viral upper respiratory tract infections get better with time and without specific treatment - so knowing the exact virus usually doesn't make any difference.
RSV can also cause lower respiratory tract infections, such as pneumonia. This is more common in older adults and people with a severely weakened immune system.
Lower respiratory tract infections can cause:
A cough - including coughing up blood.
High temperatures.
Feeling short of breath or out of breath.
Rapid or shallow breathing.
Chest pain.
Confusion.
Drowsiness.
RSV symptoms in babies and infants
RSV can cause upper respiratory tract infections in babies and infants too, with the typical cold symptoms such as:
Runny nose or blocked nose.
Cough.
High temperature.
RSV can also cause bronchiolitis. Babies and infants with bronchiolitis may have:
Cough.
Runny or blocked nose.
High temperature.
Wheezing.
Signs of difficulty breathing requiring emergency medical attention, such as:
Nostrils opening out (flaring) when breathing.
Skin between the ribs, or under the ribs, being sucked inwards when breathing (recessions).
Being too breathless to feed.
Fast or rapid breathing.
In severe cases, babies with RSV bronchiolitis can develop:
A grunting noise when breathing out.
Pauses where they stop breathing.
Blue lips or skin.
These are signs of serious breathing difficulties - call 999 or go straight to your nearest A&E if your child has any of these.
RSV causes
RSV spreads from person to person (contagious) through droplets released into the surrounding air when someone with RSV coughs or sneezes. RSV can survive on hard surfaces for several hours.
You can catch RSV by:
Breathing in RSV-containing droplets - if you are close to someone with RSV who is sneezing or coughing.
Having direct contact with someone with RSV - such as kissing the face of a baby with RSV.
Touching something with RSV-containing droplets - such as a surface that someone has sneezed or coughed on - and then touching your face or mouth with that hand.
Touching something is the most common way RSV spreads and is why washing your hands regularly helps to prevent infection.
RSV treatment
Treatment for RSV involves managing the symptoms, whilst the body clears the virus on its own. There is usually no specific treatment for RSV.
For mild RSV infections, such as the common cold, no treatment is needed - it will get better with time. Medicines can be used to treat the symptoms and make people feel better, but don't actually speed up recovery from the infection. For example:
Paracetamol or ibuprofen are useful for treating pain or fever.
Nasal saline drops or a snot sucker can help with nasal congestion in babies.
A cool mist humidifier or a steamy bath can help to ease nasal congestion.
If you have a severe RSV infection, you might need hospital treatment - this might include:
Oxygen - if your levels are low.
Intravenous fluids - if you are dehydrated.
Feeding through a tube - if you are unable to feed well enough, particularly for babies.
Breathing support with a ventilator, in severe cases.
There are some anti-viral medicines which treat RSV directly, which are:
Ribavirin.
Intravenous immunoglobulin against RSV.
There is limited evidence that these are effective and ribavirin has side-effects. So, they are only sometimes used - usually if you have a severe RSV infection, and particularly if you have a severely weakened immune system.
RSV complications
In some people - especially babies, young children, older adults, and people with a severely weakened immune system - RSV can cause complications which may mean that they need to be admitted to hospital.
RSV related infections are one of the most common reasons for children going to hospital with around 31,000 in England admitted each year. Older people are also more likely to need to be admitted to hospital for RSV-related complications.
These figures come from before the RSV vaccination programme (see below) was introduced in the UK. If enough people get vaccinated, the number of people needing hospital admission should drop substantially.
RSV complications include:
Respiratory failure - oxygen treatment may be required, and sometimes breathing support with a ventilator.
Ear infection (otitis media).
Dehydration and difficulty feeding - particularly in babies.
Death.
It's rare for RSV infections to be fatal in children in the UK, but around 20 to 30 children die each year from them.
In older people, RSV is more likely to be fatal. It's often not specifically tested for, so exact figures are difficult to confirm but it is estimated to cause 5000 to 7000 deaths in older people each winter in England and Wales.
RSV prevention
RSV can be spread from person to person.
There are things you can do to reduce the risk of catching, or spreading, the infection:
Wash your hands regularly, especially after being in public places or touching potentially-contaminated surfaces.
Avoid touching your face with unwashed hands.
Clean and disinfect regularly-touched surfaces.
Clean and disinfect toys, and other objects that children might share.
Use a tissue or your elbow to cover coughs and sneezes, and then wash your hands immediately.
Avoid close contact with people who are sick, if you can.
Stay home if you are unwell, to avoid exposing other people to the virus.
Try to avoid taking babies to crowded places - if possible.
Stop smoking - smoking make RSV illnesses worse. Children who are exposed to tobacco smoke are more likely to get bronchiolitis.
High-risk children can also be given a medicine called palivizumab (Synagis) which contains purified antibodies against RSV, which help to protect against serious infection.
In the UK, this is given to premature babies with lung disease, babies and infants with serious heart lung conditions, and babies and infants with a certain type of severe immunodeficiency.
RSV vaccine
We now have vaccines that protect against RSV infection.
In the UK, this is given to pregnant women and older adults. Giving the vaccine to pregnant women means that they produce antibodies against RSV and pass these on to their babies in the womb, meaning that their babies have protection against RSV for the first few months after birth.
See RSV vaccine for more information.
Patient picks for Viral infections
%20vaccination/og.png)
Infections
Respiratory syncytial virus (RSV) vaccination
The RSV vaccine helps protect babies and older people from the common infectious disease of the airways and lungs. Here we have information about the respiratory syncytial virus (RSV) vaccine and who should get it.
by Dr Doug McKechnie, MRCGP

Infections
How to tell the differences between winter viruses in kids
During the winter months, it's very normal for children and adults to suffer from a bout of the common cold or influenza (flu). Children in particular tend to be more susceptible to infection and can often suffer from several viruses each year. Such viruses are easily spread through contact with others, and, while a nuisance, are usually nothing to worry about.
by Gillian Harvey

Chest and lungs
The respiratory system
The lungs are divided into different parts which are called lobes. The right lung has three lobes called upper, middle and lower lobes. The left lung only has two lobes, the upper and lower.
by Dr Colin Tidy, MRCGP

Chest and lungs
Respiratory failure
Respiratory failure occurs when the breathing system fails to keep adequate blood oxygen levels. There may also be difficulties in removing waste gases, mainly blood carbon dioxide.
by Dr Colin Tidy, MRCGP

COVID-19
COVID-19: how to avoid catching viruses at work
As the final COVID-19 restrictions have been lifted in England more people are being encouraged to go back to work. But as more people begin to travel to work and mix in public areas, so the risk of catching viruses increases, whether it's colds, stomach bugs or coronavirus.
by Andrea Downey

Treatment and medication
Decongestants
Decongestants are medicines that are used to help reduce the symptoms of a blocked or stuffy nose. They may be helpful for congestion caused by various conditions. Most commonly, decongestants are used for a cold, sinusitis, hay fever, allergies and rhinitis. These medicines are available as nose drops or nasal sprays and also as tablets, capsules and syrup. Decongestant nose drops or nasal sprays should not be used for more than five days at a time. These medicines are not suitable for children under 6 years old.
by Dr Surangi Mendis, MRCGP
Frequently asked questions
What is the typical recovery time for a mild RSV infection in adults?
For mild RSV infections, such as the common cold, no specific treatment is needed, and the body will clear the virus on its own as it gets better with time.
How long can RSV survive on surfaces?
RSV can survive on hard surfaces for several hours, making cleaning and disinfecting important for prevention.
Are there any specific environments or settings that increase the risk of catching RSV?
The article suggests avoiding crowded places, especially for babies, to reduce the risk of infection. Also, being in close proximity to someone who is coughing or sneezing increases the chance of breathing in RSV-containing droplets.
What are the common pathways through which RSV spreads from person to person?
RSV primarily spreads when an infected person coughs or sneezes, releasing virus-containing droplets into the air which can then be breathed in. It can also spread through direct contact with an infected individual, such as kissing a baby, or by touching contaminated surfaces and then touching your face or mouth.
Besides vaccination, what other methods are available to protect high-risk children from severe RSV infection?
High-risk children can be given a medicine called palivizumab (Synagis). This contains purified antibodies against RSV, providing protection against serious infection. In the UK, it's typically given to premature babies with lung disease, babies with serious heart or lung conditions, and infants with certain severe immunodeficiencies.
What kind of anti-viral treatments are available for severe RSV infections, and how effective are they?
There are anti-viral medicines that directly treat RSV, such as Ribavirin and Intravenous immunoglobulin against RSV. However, the evidence for their effectiveness is limited, and Ribavirin can have side-effects. Therefore, they are usually only used in severe RSV infections, particularly in individuals with severely weakened immune systems.
Why is it more difficult to confirm the exact number of RSV-related deaths in older people?
Accurate figures for RSV-related deaths in older people are challenging to confirm because RSV is often not specifically tested for in this group.
Further reading and references
- Chatterjee A, Mavunda K, Krilov LR; Current State of Respiratory Syncytial Virus Disease and Management. Infect Dis Ther. 2021 Mar;10(Suppl 1):5-16. doi: 10.1007/s40121-020-00387-2. Epub 2021 Mar 3.
- Respiratory syncytial virus: the green book, chapter 27a; Public Health England (July 2024)
About the reviewerView full bio

Dr Krishna Vakharia, MRCGP
Chief Medical Officer for Health, Optum UK
MBChB, MRCGP(2013), BMedSci (hons), DFSRH, DRCOG, PGDipDerm (Distn)
Dr Krishna Vakharia is an NHS GP. She is also a regular examiner for the postgraduate Diploma in Practical Dermatology at Cardiff University as well as being the Chief Medical Officer for health at Optum UK.
Article history
Article also available in English, German, Spanish, French, Italian, Portuguese, Hindi, Hebrew, Arabic, and Swedish.
Next review due: 5 Nov 2027
5 Nov 2024 | Originally published
Authored by:
Dr Doug McKechnie, MRCGPPeer reviewed by
Dr Krishna Vakharia, MRCGP
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.


